BE1002749A5 - Sels de cephalosporine, melanges contenant ces sels et procede de preparation du sel d'addition d'acide sulfurique. - Google Patents

Sels de cephalosporine, melanges contenant ces sels et procede de preparation du sel d'addition d'acide sulfurique. Download PDF

Info

Publication number
BE1002749A5
BE1002749A5 BE8900051A BE8900051A BE1002749A5 BE 1002749 A5 BE1002749 A5 BE 1002749A5 BE 8900051 A BE8900051 A BE 8900051A BE 8900051 A BE8900051 A BE 8900051A BE 1002749 A5 BE1002749 A5 BE 1002749A5
Authority
BE
Belgium
Prior art keywords
salts
preparation
sulfuric acid
mixtures containing
acid added
Prior art date
Application number
BE8900051A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22510643&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE1002749(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of BE1002749A5 publication Critical patent/BE1002749A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Sels cristallins et stables à la température de 7-(alpha-(2-aminothiazol-4-yl)-alpha-(Z)-méthoxyiminoacétamido)-3-[(1-méthyl-1-pyrrolidinio)méthyl]-3-céphem-4-carboxylate choisis dans le groupe comprenant les sels d'addition d'acide sulfurique, di-nitrique, monochlorhydrique et dichlorhydrique, et les sels d'addition d'acide orthophosphorique contenant 1,5-2 équivalents molaires de H3PO4. Ces sels, mélangés avec certaines bases, donnent par dilution avec de l'eau des compositions pharmaceutiques injectables.
BE8900051A 1988-01-19 1989-01-18 Sels de cephalosporine, melanges contenant ces sels et procede de preparation du sel d'addition d'acide sulfurique. BE1002749A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/144,899 US4910301A (en) 1985-08-05 1988-01-19 Cefepime cephalosporin salts

Publications (1)

Publication Number Publication Date
BE1002749A5 true BE1002749A5 (fr) 1991-05-28

Family

ID=22510643

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900051A BE1002749A5 (fr) 1988-01-19 1989-01-18 Sels de cephalosporine, melanges contenant ces sels et procede de preparation du sel d'addition d'acide sulfurique.

Country Status (32)

Country Link
US (1) US4910301A (fr)
JP (1) JPH0725768B2 (fr)
KR (1) KR950003612B1 (fr)
AT (1) AT399878B (fr)
AU (1) AU615509B2 (fr)
BE (1) BE1002749A5 (fr)
CA (1) CA1298288C (fr)
CY (1) CY1663A (fr)
CZ (1) CZ281602B6 (fr)
DD (2) DD283397A5 (fr)
DE (1) DE3901359A1 (fr)
DK (1) DK162054C (fr)
EG (1) EG18749A (fr)
ES (1) ES2012948A6 (fr)
FI (1) FI86854C (fr)
FR (1) FR2626003B1 (fr)
GB (1) GB2213819B (fr)
GR (1) GR1001218B (fr)
HK (1) HK72292A (fr)
HU (1) HU205940B (fr)
IE (1) IE67447B1 (fr)
IT (1) IT1229528B (fr)
LU (1) LU87432A1 (fr)
NL (1) NL192266C (fr)
NZ (1) NZ227605A (fr)
OA (1) OA09227A (fr)
PT (1) PT89474B (fr)
SE (1) SE505258C2 (fr)
SG (1) SG75492G (fr)
SK (1) SK281768B6 (fr)
YU (1) YU221188A (fr)
ZA (1) ZA89407B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
DE68917574T2 (de) * 1988-12-27 1994-12-15 Chugai Pharmaceutical Co Ltd Reinigungsverfahren für 1,2-Bis(nicotinamido)propan.
CA2011116C (fr) * 1989-03-06 1999-11-16 Murray A. Kaplan Dihydrochlorure de bmy-28142 lyophilise pour usage parenteral
DE3919259A1 (de) * 1989-06-13 1990-12-20 Hoechst Ag Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung
US5698703A (en) * 1991-09-10 1997-12-16 Bristol-Myers Squibb Company Syn-isomer of thiazolyl intermediate and process for the preparation thereof
YU81692A (sh) * 1991-09-10 1995-03-27 Bristol-Myers Co. Postupak za proizvodnju cefalosporinskog antibiotika
US5594129A (en) * 1991-09-10 1997-01-14 Bristol-Myers Squibb Company Process for the preparation of a cephalosporin antibiotic
IL103110A (en) * 1991-09-10 1997-04-15 Bristol Myers Squibb Co Anhydrous process for preparing cefepime dihydrochloride hydrate
CA2099692C (fr) * 1992-07-24 2003-09-30 Gary M. F. Lim Procede de preparation d'intermediaires de la cephalosporine
CA2101571A1 (fr) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Dihydrate cristallise d'un sel de cephalosporine dihydrate; compositions injectables a base de ce compose
US5391729A (en) * 1992-09-08 1995-02-21 Bristol-Myers Squibb Company Crystalline dihydrate of a cephalosporin salt
US5401842A (en) * 1992-09-08 1995-03-28 Bristol-Myers Squibb Company Injectable compositions of a cephalosporin dihydrate salt
JPH0840907A (ja) 1994-08-03 1996-02-13 Meiji Seika Kaisha Ltd セファロスポリン注射剤
WO2005094800A2 (fr) * 2004-03-31 2005-10-13 Lupin Ltd. Composition de cefepime co-precipite et procede de preparation correspondant
EP1773845A1 (fr) * 2004-07-16 2007-04-18 Hetero Drugs Limited Procede de preparation d'intermediaires de cephalosporine pures
ITMI20051684A1 (it) * 2005-09-13 2007-03-14 Harvest Lodge Ltd Procedimento per la produzione del dicloridrato di amminoacidi
ITMI20060422A1 (it) * 2006-03-09 2007-09-10 Harvest Lodge Ltd Procedimento diretto per la produzione del dicloridrato di un amminoacido
US8151846B2 (en) * 2006-12-15 2012-04-10 Center Line Wheel Corporation Wheel having inner bead-lock
TWI400243B (zh) * 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾（ｃｅｆｑｕｉｎｏｍｅ）粒子的方法
CN103304580B (zh) * 2013-06-09 2014-07-09 四川省惠达药业有限公司 一种盐酸头孢吡肟化合物、其制备方法及其药物组合物
CN108463461B (zh) * 2015-12-10 2021-11-19 奈加-Rgm制药有限公司 头孢烯化合物、其制备和用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2116180A (en) * 1982-03-04 1983-09-21 Bristol Myers Co Cephalosporin derivatives
FR2585705A1 (fr) * 1985-08-05 1987-02-06 Bristol Myers Co Sels de cephalosporine et compositions injectables

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
CH654010A5 (de) * 1979-05-25 1986-01-31 Glaxo Group Ltd Zwischenprodukte zur verwendung bei der herstellung von cephalosporin-antibiotika.
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
US4751295A (en) * 1984-04-09 1988-06-14 Bristol-Myers Company Cephalosporin derivatives
US4749694A (en) * 1984-04-26 1988-06-07 Merck & Co., Inc. Novel lysine esters used as absorption
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
US4791196A (en) * 1986-09-26 1988-12-13 Sankyo Company Limited Crystalline cephem carboxylic acid addition salt

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2116180A (en) * 1982-03-04 1983-09-21 Bristol Myers Co Cephalosporin derivatives
FR2585705A1 (fr) * 1985-08-05 1987-02-06 Bristol Myers Co Sels de cephalosporine et compositions injectables

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 108, no. 1, 4 janvier 1988, page 541, abrégé no. 5727a, Columbus, Ohio, US; J.E. SWIGOR et al.: "Synthesis of 7-[alpha-(2-aminothiazol-4-yl)-alpha-(Z)-methoximinoacetamido]-3-(1-[14C]methylpyrrolidinio)methyl-3-cephem-4-carboxyalate sulfate", & J. LABELLED COMPD. RADIOPHARM. 1987, 24(1), 15-22 *

Also Published As

Publication number Publication date
YU221188A (en) 1990-04-30
NL192266C (nl) 1997-04-03
HU205940B (en) 1992-07-28
OA09227A (fr) 1992-06-30
PT89474B (pt) 1993-12-31
EG18749A (en) 1993-12-30
GB2213819B (en) 1991-11-27
JPH029885A (ja) 1990-01-12
SG75492G (en) 1992-10-02
DD284807A5 (de) 1990-11-28
CA1298288C (fr) 1992-03-31
DK20789D0 (da) 1989-01-18
SK24389A3 (en) 2000-12-11
DK20789A (da) 1989-07-20
FR2626003A1 (fr) 1989-07-21
AU2862389A (en) 1989-07-20
IT8947539A0 (it) 1988-01-17
US4910301A (en) 1990-03-20
FI86854C (fi) 1992-10-26
IT1229528B (it) 1991-09-04
NZ227605A (en) 1991-06-25
LU87432A1 (fr) 1989-08-30
DK162054C (da) 1992-02-10
GB8901073D0 (en) 1989-03-15
FI86854B (fi) 1992-07-15
PT89474A (pt) 1990-02-08
IE67447B1 (en) 1996-04-03
SE8900173D0 (sv) 1989-01-18
GB2213819A (en) 1989-08-23
GR1001218B (el) 1993-06-21
SE8900173L (en) 1989-01-18
CZ281602B6 (cs) 1996-11-13
ATA8589A (de) 1994-12-15
HUT50347A (en) 1990-01-29
AT399878B (de) 1995-08-25
HK72292A (en) 1992-10-02
DK162054B (da) 1991-09-09
ZA89407B (en) 1989-09-27
AU615509B2 (en) 1991-10-03
IE890144L (en) 1989-07-19
CZ24389A3 (en) 1996-08-14
FR2626003B1 (fr) 1992-10-16
SK281768B6 (sk) 2001-07-10
SE505258C2 (sv) 1997-07-21
KR890011895A (ko) 1989-08-23
CY1663A (en) 1993-05-14
NL8900111A (nl) 1989-08-16
ES2012948A6 (es) 1990-04-16
DD283397A5 (de) 1990-10-10
DE3901359A1 (de) 1989-10-05
JPH0725768B2 (ja) 1995-03-22
NL192266B (nl) 1996-12-02
FI890213A (fi) 1989-07-20
FI890213A0 (fi) 1989-01-16
DE3901359C2 (fr) 1992-04-30
KR950003612B1 (ko) 1995-04-17

Similar Documents

Publication Publication Date Title
BE1002749A5 (fr) Sels de cephalosporine, melanges contenant ces sels et procede de preparation du sel d'addition d'acide sulfurique.
ATE123221T1 (de) Kristalline 7-(2-(2-aminothiazol-4-yl)-2- hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carboxyl-säure (syn isomer).
KR940005636A (ko) 트리아졸릴티오메틸티오 세팔로스포린 염산염, 그의 수화물 결정 및 이들의 제조방법
CH649556A5 (de) Cephalosporinantibiotika, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung.
JPS5686188A (en) 7-acylamino-3-substituted cephalosporanic acid derivative and its preparation
JPS53149993A (en) 3,7-disubstituted-3-cephem-4-carboxylic acid derivatives, their salts, and their preparation
PL149550B1 (en) Method for manufacturing new,anhydrous,crystalline 5-chlor-3-(2-tenoil)-2-oxindolo-i-carbamid sodium salt
KR870001216A (ko) 3-프로페닐 세팔로스포린 용매화물
BE905219A (fr) Sels de cephalosporine et compositions injectables.
ES510068A0 (es) Procedimiento de preparacion de derivados de la familia de las cefalosporinas.
YU46689B (sh) Postupak za dobijanje kompozicija antibiotika širokog spektra stabilnih na temperaturu
DE69419037D1 (de) Feste aminoxid-maleinsäure-salze enthaltende zusammensetzungen
US5095011A (en) Lyophilized cefepime dihydrochloride for parenteral use
GB8802622D0 (en) Chemical compound
IL67285A (en) 7-(2-(2-amino-4-thiazolyl)-2-oxyiminoacetamido)-3-cephem-3-heterocyclyl-thiomethyl-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ATE28632T1 (de) Piperidin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK291786A (da) Neuroleptisk aktivt, farmaceutisk praeparat og fremgangsmaade til dets fremstilling
DE3476879D1 (en) Process for preparing benzothiazine compounds
GB2012270A (en) Crystallisation process for sodium cefuroxime
DE2965943D1 (en) Cepham compounds, pharmaceutical compositions containing them and processes for the preparation thereof and of known cephem compounds
JPH051271B2 (fr)